286 related articles for article (PubMed ID: 32444690)
41. HSCRP as surrogate marker in predicting long term effect of bariatric surgery on resolution of non-alcoholic steatohepatitis.
Tan CH; Al-Kalifah N; Lee WJ; Ser KH; Lee YC; Chen JC
Asian J Surg; 2019 Jan; 42(1):203-208. PubMed ID: 29804707
[TBL] [Abstract][Full Text] [Related]
42. Serum Ferritin and NAFLD in Patients Undergoing Bariatric Surgery.
Giacomazzi CB; Tovo CV; Moreira TR; Pase THS; Linhares AB; Coral GP; Rinaldi N; Pioner SR; De Carli LA; Fontes PRO
Obes Surg; 2022 Aug; 32(8):2658-2663. PubMed ID: 35670949
[TBL] [Abstract][Full Text] [Related]
43. Prevalence of NASH/NAFLD in people with obesity who are currently classified as metabolically healthy.
Frey S; Patouraux S; Debs T; Gugenheim J; Anty R; Iannelli A
Surg Obes Relat Dis; 2020 Dec; 16(12):2050-2057. PubMed ID: 32788075
[TBL] [Abstract][Full Text] [Related]
44. Nonalcoholic fatty liver disease in patients with different baseline glucose status undergoing bariatric surgery: analysis of intraoperative liver biopsies and literature review.
Souto KP; Meinhardt NG; Ramos MJ; Ulbrich-Kulkzynski JM; Stein AT; Damin DC
Surg Obes Relat Dis; 2018 Jan; 14(1):66-73. PubMed ID: 29104004
[TBL] [Abstract][Full Text] [Related]
45. Safety and efficacy of bariatric surgery in patients with advanced fibrosis.
Singh T; Kochhar GS; Goh GB; Schauer P; Brethauer S; Kroh M; Aminian A; Lopez R; Dasarathy S; McCullough AJ
Int J Obes (Lond); 2017 Mar; 41(3):443-449. PubMed ID: 27881858
[TBL] [Abstract][Full Text] [Related]
46. Review article: Non-alcoholic fatty liver disease in morbidly obese patients and the effect of bariatric surgery.
De Ridder RJ; Schoon EJ; Smulders JF; van Hout GC; Stockbrügger RW; Koek GH
Aliment Pharmacol Ther; 2007 Dec; 26 Suppl 2():195-201. PubMed ID: 18081662
[TBL] [Abstract][Full Text] [Related]
47. How bariatric surgery affects liver volume and fat density in NAFLD patients.
Luo RB; Suzuki T; Hooker JC; Covarrubias Y; Schlein A; Liu S; Schwimmer JB; Reeder SB; Funk LM; Greenberg JA; Campos GM; Sandler BJ; Horgan S; Sirlin CB; Jacobsen GR
Surg Endosc; 2018 Apr; 32(4):1675-1682. PubMed ID: 29218660
[TBL] [Abstract][Full Text] [Related]
48. The impact of bariatric surgery on liver enzymes in people with obesity: A 5-year observational study.
Elhelw O; Ragavan S; Majeed W; Alkhaffaf B; Mohammed N; Senapati S; Ammori BJ; Robinson JA; Syed AA
Surgeon; 2024 Feb; 22(1):e26-e33. PubMed ID: 37567846
[TBL] [Abstract][Full Text] [Related]
49. Systematic review of bariatric surgery liver biopsies clarifies the natural history of liver disease in patients with severe obesity.
Bedossa P; Tordjman J; Aron-Wisnewsky J; Poitou C; Oppert JM; Torcivia A; Bouillot JL; Paradis V; Ratziu V; Clément K
Gut; 2017 Sep; 66(9):1688-1696. PubMed ID: 27884920
[TBL] [Abstract][Full Text] [Related]
50. Effects of Bariatric Surgery on Liver Function Tests in Patients with Nonalcoholic Fatty Liver Disease.
Ooi GJ; Burton PR; Doyle L; Wentworth JM; Bhathal PS; Sikaris K; Cowley MA; Roberts SK; Kemp W; Earnest A; O'Brien PE; Brown WA
Obes Surg; 2017 Jun; 27(6):1533-1542. PubMed ID: 27966066
[TBL] [Abstract][Full Text] [Related]
51. Adipokine Levels Versus Hepatic Histopathology in Bariatric Surgery Patients.
D'Incao RB; Tovo CV; Mattevi VS; Borges DO; Ulbrich JM; Coral GP; Ramos MJ; Meinhardt NG
Obes Surg; 2017 Aug; 27(8):2151-2158. PubMed ID: 28281237
[TBL] [Abstract][Full Text] [Related]
52. CD44 is a key player in non-alcoholic steatohepatitis.
Patouraux S; Rousseau D; Bonnafous S; Lebeaupin C; Luci C; Canivet CM; Schneck AS; Bertola A; Saint-Paul MC; Iannelli A; Gugenheim J; Anty R; Tran A; Bailly-Maitre B; Gual P
J Hepatol; 2017 Aug; 67(2):328-338. PubMed ID: 28323124
[TBL] [Abstract][Full Text] [Related]
53. Microvesicular Steatosis in Individuals with Obesity: a Histological Marker of Non-alcoholic Fatty Liver Disease Severity.
Germano CW; Mega PF; Mattosinho TJAP; Dias LLC; Gestic MA; Utrini MP; Chaim FDM; Callejas-Neto F; Chaim EA; Cazzo E
Obes Surg; 2023 Mar; 33(3):813-820. PubMed ID: 36694089
[TBL] [Abstract][Full Text] [Related]
54. Correlation Between Anthropometric Measurements and Non-alcoholic Fatty Liver Disease in Individuals With Obesity Undergoing Bariatric Surgery: Cross-Sectional Study.
Reis SS; Callejas GH; Marques RA; Gestic MA; Utrini MP; Chaim FDM; Ramos AC; Chaim EA; Cazzo E
Obes Surg; 2021 Aug; 31(8):3675-3685. PubMed ID: 33982243
[TBL] [Abstract][Full Text] [Related]
55. Surgical treatment of non-alcoholic steatohepatitis and non-alcoholic fatty liver disease.
Weiner RA
Dig Dis; 2010; 28(1):274-9. PubMed ID: 20460923
[TBL] [Abstract][Full Text] [Related]
56. Role of ANGPTL8 in NAFLD Improvement after Bariatric Surgery in Experimental and Human Obesity.
Perdomo CM; Gómez-Ambrosi J; Becerril S; Valentí V; Moncada R; Fernández-Sáez EM; Méndez-Giménez L; Ezquerro S; Catalán V; Silva C; Escalada J; Frühbeck G; Rodríguez A
Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884755
[TBL] [Abstract][Full Text] [Related]
57. The metabolic and liver-related outcomes of bariatric surgery in adult patients with insulin-treated type 2 diabetes and nonalcoholic fatty liver disease at high risk of liver fibrosis.
Alkharaiji M; Anyanwagu U; Crabtree T; Idris I
Surg Obes Relat Dis; 2021 Apr; 17(4):792-798. PubMed ID: 33676874
[TBL] [Abstract][Full Text] [Related]
58. Body mass index and the visceral adipose tissue expression of IL-6 and TNF-alpha are associated with the morphological severity of non-alcoholic fatty liver disease in individuals with class III obesity.
Jorge ASB; Andrade JMO; Paraíso AF; Jorge GCB; Silveira CM; de Souza LR; Santos EP; Guimaraes ALS; Santos SHS; De-Paula AMB
Obes Res Clin Pract; 2018; 12(Suppl 2):1-8. PubMed ID: 27083404
[TBL] [Abstract][Full Text] [Related]
59. Utility of the ELF Test for Detecting Steatohepatitis in Morbid Obese Patients with Suspicion of Nonalcoholic Fatty Liver Disease.
López IC; Aroca FG; Bernal MDF; Mompeán JAL; Bernal ÁB; Martínez AMH; Barba EM; Velasco JAN; Paricio PP
Obes Surg; 2017 Sep; 27(9):2347-2353. PubMed ID: 28229316
[TBL] [Abstract][Full Text] [Related]
60. Effects of Bariatric Surgery on Non-alcoholic Fatty Liver Disease: Magnetic Resonance Imaging Is an Effective, Non-invasive Method to Evaluate Changes in the Liver Fat Fraction.
Hedderich DM; Hasenberg T; Haneder S; Schoenberg SO; Kücükoglu Ö; Canbay A; Otto M
Obes Surg; 2017 Jul; 27(7):1755-1762. PubMed ID: 28064372
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
